THE APPLICATION OF 3, 5-DIHYDROXYTOLUENE OR DERIVATIVES THEREOF IN THE PREPARATION OF MEDICINE AND FUNCTIONAL FOR TREATING OR PREVENTING DEPRESSION.
申请人:Kunming Institute Of Botany, Chinese
Academy Of Sciences
公开号:EP2193789A1
公开(公告)日:2010-06-09
The present invention relates to the application of 5-methyl-1,3-benzenediol or its derivatives represented by Formula I; wherein the constituent variables are as defined herein or pharmaceutical compositions thereof containing them in the preparation of medicines or functional foods. The present studies indicate that 5-methyl-1,3-benzenediol or its derivatives represented by Formula I, wherein the constituent variables are as defined herein or pharmaceutical compositions thereof containing them show more significant antidepressant effects than fluoxetine or imipramine.
本发明涉及 5-甲基-1,3-苯二酚或其由式 I 代表的衍生物在药物或功能食品制备中的应用,其中组成变量如本文所定义,或含有它们的药物组合物。目前的研究表明,与氟西汀或丙咪嗪相比,5-甲基-1,3-苯二酚或由式 I 代表的其衍生物(其中的组成变量如本文所定义)或含有它们的药物组合物显示出更显著的抗抑郁效果。
GARG, SHRI N.;MISRA, LAXMI N.;AGARWAL, SANTOSH K., PHYTOCHEMISTRY, 28,(1989) N, C. 1771-1772
作者:GARG, SHRI N.、MISRA, LAXMI N.、AGARWAL, SANTOSH K.
DOI:——
日期:——
The application of 3,5-dihydroxytoluene or derivatives thereof in the preparation of medicine and functional food for treating or preventing depression
申请人:Kunming Institute Of Botany, Chinese
Academy Of Sciences
公开号:EP2193789B1
公开(公告)日:2013-02-20
APPLICATION OF 5-METHYL-1,3-BENZENEDIOL OR DERIVATIVES THEREOF IN THE PREPARATION OF MEDICINES AND FUNCTIONAL FOODS FOR TREATMENT OR PREVENTION OF DEPRESSION
申请人:Chen Jijun
公开号:US20100190730A1
公开(公告)日:2010-07-29
The present invention relates to the application of 5-methyl-1,3-benzenediol or its derivatives represented by Formula I; wherein the constituent variables are as defined herein or pharmaceutical compositions thereof containing them in the preparation of medicines or functional foods. The present studies indicate that 5-methyl-1,3-benzenediol or its derivatives represented by Formula I, wherein the constituent variables are as defined herein or pharmaceutical compositions thereof containing them show more significant antidepressant effects than fluoxetine or imipramine.